Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463146
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1463146
Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global influenza medications market size is expected to reach USD 1,386.21 million by 2032, according to a new study by Polaris Market Research. The report "Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The proliferation of seasonal flu, greater prevalence of contagious respiratory illness, and increasing patient population who are at higher risk of developing flu-related complications, are key factors driving the market growth. Growing number of government initiatives like vaccination programs for controlling the spread of influenza and awareness regarding the importance of early diagnosis and treatment of influenza, are further anticipated to propel market growth.
For instance, according a report by the Centre for Health Protection in September 2023, the Government Vaccination Programme was launched in October 2023 under which the government continued to provide seasonal influenza vaccination for free of cost.
Furthermore, growing research & development activities in the field of influenza medications and growing number of pharmaceutical companies implementing on the development of more effective antiviral drugs that can treat influenza more efficiently through targeting different stages of viral, are further boosting the market's growth. For instance, according to a report by the University of Oxford in October 2023, the RECOVERY trail has been expanded for investigating treatments for influenza that cause deaths of approx. 290,000 to 650,000 people each year.
As the need for effective and safer antiviral drugs to combat the spread of influenza, companies are introducing innovative antiviral drugs like next-generation antiviral drugs which offer enhanced efficacy, broader spectrum of activity against the several influenza strains, and reduced side effects, which is impacting the demand for influenza medications in a positive way.
Additionally, ongoing advances in personalized medicine tailoring to influenza treatment based on individual patient characteristics like immune response and genetic make-up, further escalating the product demand globally. For instance, according to a study done by the Indian Institute of Science in July 2023, it is reported that picolinic acid has the potential to block various disease-causing viruses including influenza and it also help to fight against several viral diseases.
Influenza Medications Market Report Highlights
Influenza A segment accounted for notable share, owing to rising incidences and awareness regarding the importance of proper medications
Oseltamivir phosphate segment held the majority share, that is attributed to its advantages including higher efficiency and effectiveness against several strains
Online pharmacies segment will grow at highest pace, emergence of online pharmacy platforms offering several benefits to patients like convenience and easy accessibility
North America dominated the market, on account of prevalence of influenza and rising investments in R&D activities to develop new formulations
The key market players include Bayer, Roche Diagnostics, Novartis, Sanofi, AstraZeneca, AbbVie, BioCryst Pharmaceuticals, and Mylan
Polaris Market Research has segmented the influenza medications market report based on influenza type, treatment, distribution channel, and region:
Influenza Medications, Influenza Type Outlook (Revenue - USD Million, 2023 - 2032)
- Influenza A
- Influenza B
Influenza Medications, Treatment Outlook (Revenue - USD Million, 2023 - 2032)
- Baloxavir Marboxil
- Oseltamivir Phosphate
- Others
Influenza Medications, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Influenza Medications, Regional Outlook (Revenue - USD Million, 2023 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of Middle East & Africa
Product Code: PM4800
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Influenza Medications Market Insights
- 4.1. Influenza Medications Market - Distribution Channel Snapshot
- 4.2. Influenza Medications Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising incidences of influenza and increasing awareness about public health
- 4.2.1.2. Increased R&D efforts and growing regulatory
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Seasonal demand and availability of alternative treatments
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Influenza Medications Market Distribution Channel Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Influenza Medications Market, by Influenza Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 5.3. Influenza A
- 5.3.1. Global Influenza Medications Market, by Influenza A, by Region, 2019-2032 (USD Million)
- 5.4. Influenza B
- 5.4.1. Global Influenza Medications Market, by Influenza B, by Region, 2019-2032 (USD Million)
6. Global Influenza Medications Market, by Treatment
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 6.3. Baloxavir Marboxil
- 6.3.1. Global Influenza Medications Market, by Baloxavir Marboxil, by Region, 2019-2032 (USD Million)
- 6.4. Oseltamivir Phosphate
- 6.4.1. Global Influenza Medications Market, by Oseltamivir Phosphate, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Influenza Medications Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Influenza Medications Market, by Distribution Channel
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 7.3. Hospitals Pharmacies
- 7.3.1. Global Influenza Medications Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Million)
- 7.4. Retail Pharmacies
- 7.4.1. Global Influenza Medications Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
- 7.5. Online Pharmacies
- 7.5.1. Global Influenza Medications Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
- 7.6. Others
- 7.6.1. Global Influenza Medications Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Influenza Medications Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Influenza Medications Market - North America
- 8.3.1. North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.3.2. North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.3. North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.3.4. Influenza Medications Market - U.S.
- 8.3.4.1. U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.3.5. Influenza Medications Market - Canada
- 8.3.5.1. Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4. Influenza Medications Market - Europe
- 8.4.1. Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.3. Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.4. Influenza Medications Market - UK
- 8.4.4.1. UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.4.3. UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.5. Influenza Medications Market - France
- 8.4.5.1. France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.5.3. France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.6. Influenza Medications Market - Germany
- 8.4.6.1. Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.7. Influenza Medications Market - Italy
- 8.4.7.1. Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.8. Influenza Medications Market - Spain
- 8.4.8.1. Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.9. Influenza Medications Market - Netherlands
- 8.4.9.1. Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.4.10. Influenza Medications Market - Russia
- 8.4.10.1. Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5. Influenza Medications Market - Asia Pacific
- 8.5.1. Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.4. Influenza Medications Market - China
- 8.5.4.1. China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.4.3. China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.5. Influenza Medications Market - India
- 8.5.5.1. India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.5.3. India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.6. Influenza Medications Market - Malaysia
- 8.5.6.1. Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.7. Influenza Medications Market - Japan
- 8.5.7.1. Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.8. Influenza Medications Market - Indonesia
- 8.5.8.1. Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.5.9. Influenza Medications Market - South Korea
- 8.5.9.1. South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.6. Influenza Medications Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.6.4. Influenza Medications Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.6.5. Influenza Medications Market - UAE
- 8.6.5.1. UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.6.6. Influenza Medications Market - Israel
- 8.6.6.1. Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.6.7. Influenza Medications Market - South Africa
- 8.6.7.1. South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.7. Influenza Medications Market - Latin America
- 8.7.1. Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.3. Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.7.4. Influenza Medications Market - Mexico
- 8.7.4.1. Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.7.5. Influenza Medications Market - Brazil
- 8.7.5.1. Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- 8.7.6. Influenza Medications Market - Argentina
- 8.7.6.1. Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AbbVie (US)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. AstraZeneca (UK)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Bayer AG (Germany)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Bharat Biotech (India)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. BioCryst Pharmaceuticals (US)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Daiichi Sankyo (Japan)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Mylan (US)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Novartis AG (Switzerland)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Roche Diagnostics (Switzerland)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Sanofi SA (France)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Seqirus (Australia)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Product Code: PM4800
List of Tables
- Table 1 Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 2 Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 3 Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 4 Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
- Table 5 North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 6 North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 7 North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 8 U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 9 U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 10 U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 11 Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 12 Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 13 Canada: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 14 Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 15 Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 16 Europe: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 17 UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 18 UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 19 UK: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 20 France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 21 France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 22 France: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 23 Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 24 Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 25 Germany: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 26 Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 27 Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 28 Italy: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 29 Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 30 Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 31 Spain: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 32 Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 33 Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 34 Netherlands: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 35 Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 36 Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 37 Russia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 38 Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 39 Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 40 Asia Pacific: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 41 China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 42 China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 43 China: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 44 India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 45 India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 46 India: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 47 Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 48 Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 49 Malaysia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 50 Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 51 Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 52 Japan: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 53 Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 54 Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 55 Indonesia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 56 South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 57 South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 58 South Korea: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 59 Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 60 Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 61 Middle East & Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 62 Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 63 Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 64 Saudi Arabia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 65 UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 66 UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 67 UAE: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 68 Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 69 Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 70 Israel: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 71 South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 72 South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 73 South Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 74 Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 75 Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 76 Latin America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 77 Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 78 Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 79 Mexico: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 80 Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 81 Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 82 Brazil: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
- Table 83 Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
- Table 84 Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
- Table 85 Argentina: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
List of Figures
- Figure 1. Global Influenza Medications Market, 2019-2032 (USD Million)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Treatment
- Figure 7. Global Influenza Medications Market, by Treatment, 2022 & 2032 (USD Million)
- Figure 8. Market by Influenza Type
- Figure 9. Global Influenza Medications Market, by Influenza Type, 2022 & 2032 (USD Million)
- Figure 10. Market by Distribution Channel
- Figure 11. Global Influenza Medications Market, by Distribution Channel, 2022 & 2032 (USD Million)
- Figure 12. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
- Figure 13. Strategic Analysis - Influenza Medications Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.